Related Experiment Video
Updated: Jul 17, 2026

15:33
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates
Michael P Seiler1, Stephen Gottschalk, Vincenzo Cerullo
1Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Summary
Calcium phosphate (CaPi) co-precipitation significantly enhances adenoviral gene transfer into dendritic cells (DCs). This method improves DC transduction and activation, offering a promising approach for adoptive immunotherapy.
Area of Science:
- Immunology and Gene Therapy
- Cellular and Molecular Biology
Background:
- Dendritic cells (DCs) are crucial for initiating T-cell responses in immunotherapy and vaccine development.
- Adenovirus type 5 (Ad5) gene transfer to DCs is inefficient due to low expression of its cognate receptor.
Purpose of the Study:
- To improve the efficiency of adenoviral gene transfer into dendritic cells.
- To investigate the mechanism of enhanced gene transfer using calcium phosphate co-precipitation.
Main Methods:
- Co-precipitation of adenoviral vectors with calcium phosphate (CaPi).
- Transduction of mouse and human dendritic cells (DCs).
- Analysis of gene expression, viral uptake, DC maturation markers (CD40, CD86), and cytokine secretion (TNF-α, IL-6).
Main Results:
- CaPi co-precipitation increased gene expression by 2000-fold and transduction efficiency by 50-fold in mouse DCs.
- Enhanced transduction was primarily due to receptor-independent viral uptake.
- Ad5:CaPi treatment activated DCs, increasing CD40 and CD86 expression and proinflammatory cytokine secretion.
Conclusions:
- CaPi co-precipitation is a simple and effective technique to enhance Ad5 gene transfer into DCs, independent of viral receptor interactions.
- This method combines adenoviral delivery efficiency with nonviral gene delivery's receptor independence.
- The enhanced gene transfer can functionally modify DCs to activate antigen-specific T-cells, supporting clinical adoptive immunotherapy.

